Cellular proliferation and survival are modulated by the expression of speci®c genes. Cytokine response gene 8 (CR8), which was originally cloned as an IL-2-induced gene in human T lymphocytes, encodes a basic helix ± loop ± helix (bHLH) transcription factor. The CR8 gene product is highly conserved among human, mouse and rat, and contains sequence motifs that distinguish it from other bHLH families. The CR8 gene is ubiquitously expressed, and CR8 gene expression is induced by both growth-promoting as well as growth-inhibitory stimuli. As bHLH proteins have been found to regulate both the G1-S phase cell cycle transition, as well as cellular survival, the eects of CR8 on these processes were investigated. Ectopic CR8 expression in asynchronous U2OS cell cultures reduces the percentage of cells in the cell cycle S phase, and also slows the entry of G1-synchronized cells into S phase. The prolonged G1 interval correlates with impaired elevation of cyclin E protein and prolonged p21 protein expression in G1. CR8 expression also protects U2OS cells from serum-withdrawal induced apoptosis. These results indicate that CR8 is an important modulator of both the G1-S phase cell cycle transition, and cellular survival. Oncogene (2001) 20, 1771 ± 1783.
Introduction
Cellular proliferation and survival are tightly controlled processes. Extracellular stimuli, such as cytokines and growth factors, often provide dual signals to target cells, which regulate the G1/S phase cell cycle transition, and also protect cells from undergoing apoptosis. Basic helix ± loop ± helix (bHLH) transcription factors have emerged as key regulators of both cell cycle progression and survival. bHLH proteins are characterized by a basic region which binds DNA, and an adjacent dimerization domain of *50 amino acids which contains two amphipathic a helices separated by a loop of variable length (reviewed in Murre et al., 1994; Massari and Murre, 2000) . The DNA binding site for bHLH proteins, which was originally identi®ed in the IgH intronic enhancer and so termed an E-box (Murre et al., 1989) , contains the consensus CANNTG.
Several general classes of HLH proteins have been de®ned based on the ability to homo-and hetereodimerize, and on their tissue distribution patterns. The bHLH-leucine zipper proteins, including c-myc, contain a leucine repeat adjacent to the HLH region, and interact only with other zipper-containing bHLH proteins. Among the non-zipper HLH proteins, the Class I HLH proteins, also termed E-proteins, include the E2A gene products E47 and E12. These bind DNA as both homo-and heterodimers, and are ubiquitously expressed. The Class II bHLH proteins, such as MyoD, only bind DNA as heterodimers with Class I proteins, and exhibit a very narrow range of tissue distribution. The Id family proteins contain an HLH region, but lack a basic DNA binding domain. The Id proteins interfere with bHLH protein activity by sequestering bHLH proteins in non-DNA-binding heterocomplexes (reviewed in Massari and Murre, 2000) .
Initiation of cellular proliferation is governed by members of the Class I and Class II bHLH families, as well as the Id family. Cell cycle inhibitory bHLH proteins, such as those encoded by the E2A and MyoD genes, act in G1 to impede entry into the cell cycle S phase. The cell cycle-inhibitory bHLH proteins set a threshold for titration of the growth-promoting Id proteins, which are expressed in early G1 Deed et al., 1993) . The growth factor-induced elevation of Id expression leads to disruption of cell cycle inhibitory bHLH complexes, and thereby alleviates the block of the G1-S phase transition. Consequently, the relative levels of HLH proteins expressed in G1 set a balance which governs the subsequent initiation of DNA replication .
bHLH proteins have also been implicated in the regulation of growth factor-withdrawal-induced apoptosis. For example, the Tal1 gene product, which is normally expressed in hematopoietic cells, and is also expressed abnormally in some cases of T cell acute lymphoblastic leukemia (T-ALL) as a result of chromosomal aberrations, protects IL-3-dependent 32D cells from cytokine-withdrawal-induced apoptosis (Condorelli et al., 1997) . Loss of Tal1 has also been reported to result in increased sensitivty of Jurkat cells to serum-withdrawal-induced apoptosis (Leroy-Viard et al., 1995) . Notably, two bHLH proteins, Dermo1 and twist, were identi®ed in a screen for genes which could protect from serum-withdrawal and c-myc overexpression-induced apoptosis of Rat1 ®broblasts (Maestro et al., 1999) .
Recently, a bHLH protein was identi®ed that appears to de®ne a novel subclass. Dear et al. (1997) isolated the murine E47-interacting protein 1 (eip 1) in a screen for E47 heterodimerization partners that bind the E-box sequence CACGTG. Subsequently, Boudjelal et al. (1997) identi®ed the same gene in a screen for transcripts expressed upon retinoic acid (RA)-induced dierentiation of p19 embryonal carcinoma cells. The gene was termed STRA13 for stimulated with RA gene 13. The rat homologue, SHARP2, was identi®ed as an enhancer of split and hai r y -related protein expressed in rat brain (Rossner et al., 1997) , while the human homologue, DEC1, was identi®ed by virtue of its induced expression in dierentiated embryonic chondrocytes treated with Bt2cAMP (Shen et al., 1997) and in 3T3LI adipocytes induced to dierentiate by insulin (Inuzuka et al., 1999) . Based upon the stimuli which were used to induce expression of this gene, the gene product was proposed to play a role in cellular dierentiation.
Prior to these reports, we described the cloning of immediate-early genes induced in human T lymphocytes by the T cell growth factor interleukin-2 (IL-2) (Beadling et al., 1993) . Herein, we report that one of these cytokine responsive (CR) genes, CR8, is identical to the human DEC1 gene. This gene product is highly conserved among human, mouse and rat, and sequence motifs that distinguish the CR8 protein from other bHLH families are strictly maintained among all three species. The CR8 gene is constitutively expressed in a wide variety of adult tissues, and also exhibits inducible expression in response to both growth promoting as well as growth inhibitory stimuli. The CR8 expression pattern indicates that the function of the CR8 gene product is not limited to the promotion of cellular dierentiation. Indeed, we ®nd that ectopic CR8 expression demonstrates that CR8 is an important regulator of both the G1-S phase cell cycle transition and cellular survival.
Results
The IL-2-induced CR8 gene encodes a highly conserved bHLH protein
The original human CR8 clone isolated from an IL-2-induced T cell cDNA library contained a partial cDNA, so that full-length cDNA clones of human CR8 were subsequently isolated from a human T cell cDNA library by screening with the original CR8 cDNA probe. Two independent full-length cDNA clones were sequenced, and found to encode an identical deduced 412 amino acid open reading frame (Figure 1 ). CR8 is identical to the human DEC1 gene (Shen et al., 1997) . The putative murine homologue, designated EIP1 (Dear et al., 1997) and STRA13 (Boudjelal et al., 1997) , shows 92% amino acid identity with CR8, and the rat SHARP2 (Rossner et al., 1997 ) is 91% identical. There is complete identity among all three proteins within the bHLH domain, spanning amino acids 53 ± 112.
The bHLH domain of the CR8 protein shares *40% amino acid identity with Drospohila hairy and enhancer of split (Sasai et al., 1992) . CR8 also contains a Pro residue in the bHLH region, which is oset Nterminally by two residues relative to the hairy-related proteins. Unlike hairy family proteins, CR8 lacks a Cterminal WRPW motif (Fisher et al., 1996; Massari and Murre, 2000) . CR8 does possess four Gln residues immediately C-terminal to the bHLH region, which are not found in hairy family members. All of these features are conserved among human, mouse and rat CR8. Thus, while CR8 is most similar to the hairy family of bHLH proteins, these sequence dierences indicate that it comprises a distinct subclass of bHLH proteins.
CR8 gene expression is regulated by cytokines
To begin to address possible biological functions of CR8, the expression pattern of the CR8 mRNA was assessed. Northern blot analysis of RNA isolated from various adult and fetal human tissues demonstrates that while the 3.2 kb CR8 transcript is expressed constitutively at highest levels in lung, liver, and skeletal muscle, the transcript is readily detected in all tissues examined except placenta (Figure 2 ). Comparable levels of expression were detected in both fetal and adult tissues. Finding expression of CR8 in freshly isolated peripheral blood leukocytes was unexpected, in that CR8 is not highly expressed by quiescent T cells. The contribution of other leukocytes, such as natural killer cells, monocytes and granulocytes, could account for CR8 expression by the unstimulated peripheral blood leukocytes. Overall, the high level of expression in adult tissues indicates that CR8 function is not restricted to embryonic development.
To investigate further CR8 expression, patterns of cytokine-inducible CR8 gene expression were tested, using as a standard the pre-activated, G1-synchronized human peripheral blood T cells from which CR8 was originally cloned. CR8 expression was compared in the IL-2-dependent human CD4+ T cell line Kit225, the CD8+ murine T cell line CTLL-2, and the murine IL-3-dependent pro-B cell line Ba/F3. These cell populations were G1-synchronized by brief cytokine withdrawal, then restimulated with either IL-2 or IL-3 for 2 h. A human osteosarcoma cell line, U2OS, was also tested, after G1-synchronization and 2 h restimulation with 10% serum. Northern blot analysis of total cellular RNA isolated from these cell populations CR8 regulates G1 progression and cellular survival C Beadling et al indicates that CR8 expression is very low in quiescent cells, then highly induced upon stimulation with the respective cytokines ( Figure 3a) . Thus, CR8 expression is induced by IL-2 in both CD4+ and CD8+ T cells, by IL-3 in pro-B cells, and by serum in U2OS cells. As IL-2, IL-3 and serum are growth-promoting stimuli, the induction of CR8 expression by these agents suggested that CR8 may be involved in promoting cellular proliferation. Therefore, the relationship between the level of CR8 gene expression and that of cytokine-stimulated DNA synthesis was examined by using growth-inhibitory agents. Interferons (IFNs), and agents which increase intracellular cAMP exert antiproliferative activity on many cell types. Therefore, G1-synchronized Kit225 cells were stimulated with IL-2 and treated simultaneously with IFNb, or forskolin, which increases cytoplasmic cAMP by activating adenylate cyclase. IL-2-dependent [ 3 H]thymidine incorporation was inhibited by both IFNb and forskolin in Kit225 cells in a dose-dependent fashion ( Figure 3b ). Figure 3c shows that CR8 transcripts were induced by IL-2. Somewhat unexpectedly, CR8 transcripts were also induced by IFNb and forskolin alone. Furthermore, IFNb and forskolin did not suppress the IL-2-induced expression of CR8 transcripts. Thus, paradoxically, CR8 transcripts are induced by cytokines which promote DNA replication, and as well, by agents which suppress DNA replication.
CR8 slows G1-S phase cell cycle progression
To facilitate analysis of the biological function of CR8, cell lines were established with an inducible CR8 construct. For these experiments, the U2OS osteosarcoma cell line was used. These cells possess intact cell cycle checkpoint proteins, Rb and p53, are dependent upon serum growth factors for proliferation, and as well, they undergo apoptosis upon serum withdrawal (Niculescu et al., 1998) . Stable clones were derived using a ponasterone A-inducible expression system. Cells were transfected with the pVgRXR plasmid, which encodes a modi®ed drosophila ecdysone receptor, and the retinoid X receptor. The CR8 cDNA was cloned into the pIND plasmid, downstream of a steroid receptor response element. In the presence of ponasterone A, the pVgRXR-encoded receptors dimerize, and activate transcription of the transfected CR8 cDNA. Several clones were isolated, and CR8 expression was assessed by Western blot. Figure 4a shows the inducible expression of the *47 kDa CR8 protein in clones CR8#3, #8 and #9. The level of expression in clone 3 is lowest, with slightly higher levels in clone 8, and highest expression in clone 9. Vector control transfected cells (N) show no ponasterone inducible CR8 protein expression.
To test the eects of CR8 expression on cell growth, asynchronous cultures of U2OS cells were treated for 48 h with ponasterone A to induce CR8, or left untreated. Cell cycle analysis was subsequently performed by DNA staining with propidium iodide (PI). As shown in Figure 4b , ectopic expression of CR8 caused a reduction in the percentage of cells in S phase, with a DNA content between 2N ± 4N. In the case of clones 3 and 8, induction of CR8 expression caused a reduction from 30% of cells in S phase to 18 ± 22%. Clone 9 showed a reduction from 35 to 21% after CR8 induction. Control cells, transfected with empty vector (N), showed no change in cell cycle distribution after ponasterone A treatment. To investigate further the eects of CR8 on cell cycle progression, G1-synchronized cultures of U2OS cells were prepared. Upon replating in complete medium, the cells traverse G1 and begin to enter S phase after approximately 15 ± 18 h. This rate of G1 exit was observed in vector control cells in the absence or presence of ponasterone A, and also in all three CR8 clones when CR8 was not induced with ponasterone A (Figure 4c ). Thus, starting with approximately 20 ± 30% non-G1 cells (cells with 42N DNA content) at the time of replating, within 24 h approximately 60% of cells in these cultures had left G1. However, when CR8 expression was induced, the exit from G1 was slowed, so that after 24 h, the percentage of CR8-expressing cells that had left G1 had increased only marginally, to *35%. Thus, CR8 expression reduces the percentage of cells in S phase in asynchronous cultures, and slows exit from G1 of synchronized cultures.
CR8 impairs cyclin E induction
Cyclin E is a key regulator of the G1-S phase transition, and two populations of G1 cells have been described based on the levels of cellular cyclin E protein. Thus, early G1 (G1a) cells have low cyclin E, while late G1 (G1b) cells, exhibit elevated levels of cyclin E protein. These populations are readily expression is induced by both growth promoting and growth inhibitory stimuli. (a) Induction of CR8 transcript by growth factors. Peripheral blood-derived human T cells, the IL-2-dependent human T cell line Kit225, the IL-3-dependent mouse pro-B cell line Ba/F3, the IL-2-dependent mouse T cell line CTLL-2, and the human osteosarcoma cell line U2OS were made quiescent by brief growth factor withdrawal. Cells were then left untreated or stimulated for 2 h with 500 pM recombinant human IL-2, 10 U/ml recombinant mouse IL-3, or 10% fetal calf serum (FCS) as indicated. Ten micrograms of total RNA were subjected to Northern blot analysis with either human (lanes 1 ± 4, 9 ± 10) or mouse (lanes 5 ± 8) CR8 cDNA probes. (b) IFNb and forskolin inhibit IL-2-dependent [ 3 H]thymidine incorporation by Kit225 cells. Quiescent Kit225 cells were incubated with 500 pM IL-2 alone, or in combination with varying concentrations of IFNb (U/ml) or forskolin (mM) as indicated. Cells were pulsed with [ 3 H]thymidine for the ®nal 4 h of a 28 h culture period to monitor DNA synthesis. (c). Antiproliferative agents induce the expression of CR8 transcripts in Kit225 cells. Quiescent Kit225 cells were left untreated or incubated for 2 h with 500 pM IL-2, 1000 U/ml IFNb, 100 mM forskolin, IL-2+IFNb or IL-2+forskolin, as indicated. Northern blot analysis was performed with a human CR8 cDNA probe. Total RNA was detected by ethidium bromide stain CR8 regulates G1 progression and cellular survival C Beadling et al distinguished by¯ow cytometric analysis with dual staining for DNA content and cyclin E protein (Gong et al., 1994) . Intracellular cyclin E levels were therefore monitored in cultures of U2OS clone CR8#9 after G1 synchronization, and at intervals after restimulation with serum. As shown in Figure 5 , in the absence of ponasterone induction of CR8 expression, G1-synchronized cells exhibit a low level of cyclin E expression which increases after 12 ± 16 h of serum stimulation.
Once cells have surpassed a threshold level of cyclin E, there is a transition from 2 N to 42 N DNA content, as cells rapidly begin to enter S phase after *16 h. After 20 ± 24 h serum stimulation, cells not treated with ponasterone exhibit distribution throughout all phases expression had been induced with ponasterone prior to serum stimulation, the transition from low to high cyclin E was retarded, as the cells remained in the G1a stage for a more prolonged interval. While a fraction of the CR8-expressing cells were able to elevate cyclin E levels and enter S phase, even after 24 h of serum stimulation *60% of the cells were still in G1. The vast majority (*80%) of these G1 cells remained in G1a, with low levels of cyclin E expression. No eect of ponasterone was observed in vector-transfected control cells (data not shown, and Fan et al., 1999) . Therefore, the slowed entry of CR8-expressing cells into S phase is re¯ected by the diminished capacity to elevate cyclin E protein levels.
CR8 prolongs p21 expression in G1
The cyclin dependent kinase inhibitor (CKI) p21 has been implicated in the regulation of cell cycle transit by bHLH proteins (Halevy et al., 1995; Prabhu et al., 1997) . Intracellular p21 levels and DNA content were therefore monitored in U2OS cells in the absence or presence of CR8, after G1 synchronization and restimulation with serum. As shown in Figure 6a , p21 expression is highest in cells with 2 N and 4 N DNA content, and lowest in S phase cells. These results are consistent with the requirement for G1 cells to degrade p21 prior to S phase entry. Figure 6b presents the p21 expression levels of G1 cells expressed as the percentage of p21 positive cells relative to the level in the control G1-synchronized cultures prior to serum restimulation. In vector control-transfected cells with or without ponasterone A treatment, or in U2OS clone CR8#9 cultures not treated with ponasterone A, the percentage of p21+ G1 cells increases modestly (*30%) after 12 h restimulation with serum. The percentage then declines to *30% of the initial level after 24 h. By comparison, in the CR8-expressing cultures, there is an increase of *2.5-fold after 12 h restimulation. While this percentage declines over time, it remains greater at 12 h than at the initiation of the serum restimulation. To determine whether the increased levels of p21 expression in CR8-expressing cells re¯ected augmented induction of p21, or impaired diminution of p21 expression, more detailed kinetic analysis was perfomed. Figure 6c shows the levels of p21 expression observed in U2OS clone CR8#9 at various time points after serum stimulation of G1-synchronized cultures. In control cultures, there is a *twofold increase in p21 expression after 3 h, and a maximum fourfold induction at 6 ± 9 h. The p21 expression then drops precipitously from 9 ± 12 h. In cultures treated with ponasterone A to induce CR8 expression, the initial increase of p21 up to 9 h is identical to that observed in control cultures. However, the decline in p21 expression from 9 ± 12 h is signi®cantly reduced. Ponasterone treatment had no eect on vectortransfected control cultures (data not shown, and Fan et al., 1999) . It should be noted that in these experiments, CR8 expression is pre-induced for *12 h prior to serum restimulation of the cultures. Thus, these results suggest that CR8 does not directly promote p21 expression, as CR8 does not change the basal level of p21 expression prior to serum restimulation, nor does CR8 alter either the magnitude or kinetics of the induction of p21 expression observed between 3 ± 9 h of serum stimulation. Instead, CR8 expression delays the decrease in p21 expression normally observed in late G1.
CR8 promotes cell survival
Gene products that retard cell cycle progression by prolonging the duration of the gap phases of the cell cycle often also prevent programmed cell death. Therefore, the eects of CR8 expression on apoptosis induced by serum withdrawal were investigated, as U2OS cells are dependent upon serum-derived growth factors for survival. CR8 clones 3, 8 and 9 cultured in the absence of ponasterone A exhibit approximately 40 ± 45% of cells with a 52 N DNA content after serum deprivation for 6 days, as detected by PI staining (Figure 7a ). By comparison, induction of CR8 expression reduced the appearance of the 52 N DNA population in cultures of CR8 clones 3 and 8 to approximately 23 ± 29%, and in CR8 clone 9 to *10%. Parallel cultures maintained in 10% serum showed 51% apoptotic cells in all cases, and ponasterone A treatment had no eect on the apoptosis of vector control cells. Thus, serum-withdrawal-induced DNA degradation is antagonized by CR8 expression.
Upon serum withdrawal, U2OS cells also undergo morphological changes, including a decrease in cell size, and the loss of the normally smooth contour. These changes are detectable by¯ow cytometry as shifts in the forward and side scatter pro®les. Vector controltransfected cells (U2OS N) irrespective of ponasterone A treatment, and CR8 clone #9 cells not treated with ponasterone A, show reduced forward and side scatter pro®les after serum withdrawal (Figure 7b ). In the presence of 10% serum, only 1.5 ± 3.5% of the cells exhibit this pro®le, while 55 ± 63% of serum-deprived cells exhibit this morphology. By comparison, ponasterone A-induced expression of CR8 reduces this population to 12.5% in serum-deprived CR8 clone #9 cultures. Thus, CR8 expression antagonizes the morphological changes and the appearance of cells with 52 N DNA content initiated by growth-factor withdrawal.
Discussion
CR8 is a highly conserved, ubiquitously expressed gene product which regulates both cell cycle progression and cellular survival. CR8 appears to set a threshold for the titration of G1-S phase progression signals, as CR8 expression prolongs G1. CR8 also antagonizes apoptosis, enhancing the survival of cells after growth factor withdrawal. The previously reported IL-2-induced gene CR8 encodes a bHLH protein which maintains complete identity within the bHLH region among human, mouse and rat, and 491% overall amino acid identity among all three species (Beadling et al., 1993; Dear et al., 1997; Boudjelal et al., 1997; Rossner et al., 1997; Shen et al., 1997) . A Pro residue in the basic region, and a 4 Gln repeat just C-terminal to the bHLH region are conserved in all three species, and appear to de®ne a unique subfamily of bHLH protein. Although CR8 is related to the hairy and E(spl) family, with *40% identity within the bHLH region, the CR8 protein lacks the conserved WRPW motif found in the Cterminus of hairy proteins (Fisher et al., 1996; Massari and Murre, 2000) . As the hairy WRPW motif is used to recruit transcriptional repressors, the CR8 protein would be predicted to lack this function. Murine CR8 has nonetheless been reported to act as a transcriptional repressor (Boudjelal et al., 1997) , and the repressor activity has been mapped to predicted ahelices near the C-terminal portion of the protein which recruit a histone deacetylase (Sun and Taneja, 2000) . Notably, Rossner et al. (1997) have reported the identi®cation of rat sharp1, which is 95% identical to the rat CR8 homologue (designated sharp2) within the bHLH region, and 57% identical to rat CR8 overall. Like rat CR8, sharp1 contains a Pro in the same position of the basic region, lacks a WRPW motif, and has a QQHQ motif in the same position as the QQQQ motif of CR8. Thus, the CR8 proteins de®ne a new structural bHLH family.
Clearly, the ubiquitous expression of CR8 which we have observed in numerous adult human tissues, and the cytokine-inducible expression in lymphocytes indicate that CR8 functions are not limited to cellular dierentiation. We originally cloned the human CR8 gene from IL-2-treated human peripheral blood T cells (Beadling et al., 1993) . CR8 is induced by IL-2 in both CD4 + and CD8 + T cells, and also by IL-3 stimulation of pro-B cells. In these systems, IL-2 and IL-3 provide growth stimulatory signals, and drive cells from G1 into the cell cycle S phase. Somewhat paradoxically, growth inhibitory stimuli, such as IFN and agents that elevate intracellular cAMP, also induce CR8 expression in T cells. It is possible that CR8 may function in the G1 phase of the cell cycle to prevent premature entry of cells into S phase, in a manner analogous to the yeast protein p25rum1 (Moreno and Nurse, 1994) .
Consistent with this hypothesis, ectopic expression of CR8 in U2OS cells slows exit from the G1 phase of the cell cycle. This phenotype is manifested as a diminution of the percentage of cells with 42 N DNA content, and is similar to that which has been observed by BrdU labeling of NIH3T3 cells expressing E47 or MyoD , as well as CV1 and U2OS cells transiently transfected with MyoD (Halevy et al., 1995) . Murine CR8 has also been reported to reduce colony formation of NIH3T3 cells by approximately ®vefold (Sun and Taneja, 2000) . The growth inhibitory eect of CR8 contrasts with the growth promotion mediated by Id proteins. Over-expression of Id1 in NIH3T3 cells (Prabhu et al., 1997) , and Id1, Id2 or Id3 in rat embryo ®broblasts Norton and Atherton, 1998) promotes S phase entry. Moreover, inhibition of Id function by neutralizing antibody or antisense oligonucleotides ) blocks growth factor induced S phase entry. Thus, in the balance of HLH proteins that govern S phase entry, CR8 favors growth inhibition, in opposition to the Id proteins.
The HLH regulation of S phase entry occurs at a point preceding the G1 restriction point. Thus, ectopic E47 expression or microinjection of anti-Id antisera must take place within 8 h after serum restimulation of G1-synchronized NIH3T3 cells in order for the inhibition of subsequent S phase entry to occur . This indicates that once cells traverse the G1 restriction point, HLH proteins are no longer able to impede the initiation of DNA replication. A key mediator of the G1 restriction point is cyclin E. In order for cells to traverse this checkpoint, cyclin E must be expressed above a threshold level. Bivariate DNA and cyclin E protein staining, with detection by¯ow cytometry, enables the discrimination of two populations of G1 cells. Those with low cyclin E expression reside in G1a, while increased cyclin E expression de®nes the G1b population (Darzynkiewicz et al., 1996) . CR8 expression in U2OS cells impedes the transition from G1a to G1b. Thus, while a few cells are able to increase cyclin E expression normally and enter S phase, the majority of those that do not leave G1 remain in G1a.
The degradation of p21 is required to enable the initial cyclin E/CDK2 activation in mid G1, which then promotes complete Rb phosphorylation, and subsequent E2F activation. This increase in E2F activity results in transcriptional activation of E2F target genes, including cyclin E itself (Reviewed in Sherr 1994 Sherr , 1996 . Therefore, delayed p21 degradation would prevent the complete elevation of cyclin E expression required to exit G1. In G1-synchronized U2OS cells expressing CR8, the induction of p21 expression observed after 3 ± 9 h serum restimulation is indistinguishable from control cultures. However, the subsequent p21 down regulation which occurs between 9 ± 12 h in control cultures, just preceding cyclin E elevation and S phase entry, is markedly impaired upon CR8 expression. Although CR8 expression was pre-induced prior to serum restimulation of cultures, there was no eect on the basal p21 expression, or on the magnitude or kinetics of serum-induced p21 expression. Thus, CR8 impairs p21 downregulation, which may contribute to the slow G1 exit of CR8-expressing cells.
E47 and MyoD have been reported to increase p21 gene transcription through E-box sites in the p21 promoter, and Id1 suppresses p21 expression via these E box sites (Halevy et al., 1995; Prabhu et al., 1997) . However, a similar direct eect of CR8 on the p21 promoter is unlikely, as described above, because CR8 does not aect the initial serum-induced increase in p21 expression, only the subsequent down-regulation.
Moreover, murine CR8 functions as a transcriptional repressor, not an activator (Boudjelal et al., 1997; Sun and Taneja, 2000) . An alternative mechanism may be that CR8 sequesters Id proteins, or proteins with Idlike activity. Because Id proteins trigger p21 downregulation (Prabhu et al., 1997) , CR8 antagonism of this function would result in the observed heightened p21 expression.
CR8 also inhibits growth factor-withdrawal-induced apoptosis. Thus, there is a signi®cant reduction in the percentage of U2OS cells that exhibit 52 N DNA content after serum withdrawal when CR8 is expressed, compared to control cultures. Florio et al. (1998) have reported that ectopic Id2 expression in U2OS cells triggers apoptosis, as after 4 days 67% of cells expressing Id2 have 52 N DNA content. Id2 also promotes apoptosis in 32D myeloid cells, and deletion of the Id2 HLH domain accentuates this activity. Thus, proteins interacting with the HLH domain may impair the apoptosis-promoting activity of Id2, underscoring the balance among HLH proteins in the regulation of apoptosis (Florio et al., 1998) . This point is further demonstrated by the observation that Id3-promoted apoptosis of REF cells is antagonized by E47 (Norton and Atherton, 1998) , and that Tal-1 antagonism of IL-3-withdrawal induced 32D cell apoptosis is impaired when the Tal-1 HLH domain is mutated (Condorelli et al., 1997) . Accordingly, CR8 promotes cellular survival in this balance between apoptosis-promoting and antagonizing HLH proteins. Therefore, identi®cation of CR8 target genes should shed new light on the means whereby bHLH proteins regulate cell growth and survival.
Materials and methods

Cell culture methods and reagents
Human T cells were prepared as described previously (Fan et al., 1999; Beadling et al., 1993; Gullberg and Smith, 1986) . Kit225 is an IL-2-dependent human T cell line, CTLL-2 is a murine IL-2-dependent T cell line, and Ba/F3 is a murine pro-B cell line dependent on IL-3. Both Kit225 and CTLL-2 were maintained in RPMI 1640 medium supplemented with 10% FCS and 500 pM recombinant human IL-2. Ba/F3 cells were maintained in RPMI 1640 supplemented with 10% FCS and 5% conditioned medium from ®broblasts transfected with the murine IL-3 cDNA, or with recombinant murine IL-3 (Genzyme). Cell lines were made quiescent by growth factor deprivation for 72 h for Kit225, 12 h for Ba/F3 and 2 h for CTLL-2. Proliferation was monitored by incorporation of [ cDNA library screening lgt10 cDNA libraries were constructed and screened according to standard procedures. Poly(A) + RNA was isolated from IL-2-stimulated normal human T cells (Beadling et al., 1993) , and cDNA synthesis was primed with both oligo(dT)12 ± 18 and random hexamers. The recombinant phage were screened with a radiolabeled 1.5 kb CR8 cDNA probe (Beading et al., 1993) .
Sequence analysis
The CR8 cDNA sequence was determined using thē uorescence-based dideoxynucleotide termination method (Taq DyeDeoxy Terminator Cycle Sequencing Kit, Perkin Elmer) and the Applied Biosystems 373A DNA sequencer. Consensus sequences were constructed with the University of Wisconsin GCG software package. The BLAST algorithm from the National Center for Biotechnology Information was used for nucleotide and amino acid sequence homology searches.
Northern hybridization
Total cellular RNA was isolated by RNAzol B (Tel-Test), fractionated on a 1.2% agarose formaldehyde gel, visualized with ethidium bromide, and then transfered to Hybond-N + nylon membrane (Amersham). Multiple tissue Northern blot membranes were purchased from Clontech. Membranes were hybridized with 32 P-labeled cDNA probes for 3 h to overnight at 658C in Rapid-Hyb hybridization solution (Amersham), washed twice with 26SSC/0.1% SDS (16SSC=150 mM Nacl, 15 mM sodium citrate, pH 7.0) at room temperature for 15 min, once with 0.56SSC/0.1% SDS at 608C for 15 min, and subjected to autoradiography.
Stable CR8-expressing cell lines
The CR8 cDNA comprising the complete open reading frame was cloned into the pIND plasmid (Invitrogen). U2OS osteosarcoma cells were transfected with the pIND-CR8 and pVgRXR (Invitrogen) plasmids, and selected in neomycin and zeocin. Drug-resistant clones were screened for ponasterone-A-induced CR8 expression by Western blot with anity-puri®ed CR8 antisera raised against the fulllength human CR8 protein. For cell cycle analysis of asynchronous cultures, cells were treated with 2.5 mM ponasterone A or vehicle (0.1% ethanol) control, and harvested 48 h after plating. To synchronize cell cultures, cells were plated in complete medium supplemented with 10% FCS, allowed to grow to con¯uence, then placed in medium supplemented with 0.5% FCS for 24 h. Cells were pre-treated with 2.5 mM ponasterone A or 0.1% ethanol control for 12 ± 14 h prior to replating in medium supplemented with 10% FCS. For apoptosis analysis, cells were pre-treated with 2.5 mM ponasterone A or 0.1% ethanol control for 12 ± 14 h, then placed in medium without FCS.
Intracellular protein and DNA staining
For intracellular DNA, cyclin E, and p21 staining, cells were harvested, washed in PBS, and ®xed in ice-cold 80% ethanol. Intracellular staining was performed as described (Gong et al., 1993 (Gong et al., , 1994 Darzynkiewicz et al., 1996; Fan et al., 1999) , using cyclin E (Pharmingen, clone HE12), p21 (Pharmingen, clone SX118) and control lgG (Pharmingen) antibodies at a ®nal concentration of 2.5 mg/ml. FITC-conjugated goat antimouse secondary antibody (Jackson Labs) was used in conjunction with 10 mg/ml propidium iodide and 10 mg/ml RNAse A. For detection of apoptotic cells with 52 N DNA content, ethanol-®xed cells were stained with 50 mg/ml Pl and 10 mg/ml RNAse A. Samples were analysed on a FacsCalibur ow cytometer, using CellQuest software.
